Bostwick Laboratories to Slash 58 Pct of Its Staff
12/13/2012 8:29:09 AM
More...
|
Gynecor™, a Division of Bostwick Laboratories, Adds New State-of-the-Art Lab Technology to Help Physicians Identify Patients at Risk for Cervical Cancer, Improve Treatment Decisions
9/26/2012 8:56:44 AM
More...
|
Bostwick Laboratories Completes Growth Recapitalization with Metalmark Capital
10/25/2011 11:18:42 AM
More...
|
Bostwick Laboratories: New Personalized Genetic Test- ProstaVysionTM- Helps Prostate Cancer Patients Make Best Treatment Decisions
5/12/2011 11:24:51 AM
More...
|
Bostwick Laboratories Release: Announcing American International Biotechnology Services; Bostwick Acquires Assets and
Infrastructure of CBI Services and Fairfax Identity Laboratories
11/3/2009 8:59:06 AM
More...
|
Gastrocor(R) Introduces New FISH Test for Colorectal Cancer Detection
10/30/2009 12:24:23 PM
More...
|
Sangretech Biomedical and Bostwick Laboratories Announce Amended License for Sangretech's Dendritic Cell Technology
10/15/2009 8:33:55 AM
More...
|
Commonwealth Biotechnologies, Inc. (CBTE) Enters Into Agreement With Bostwick Laboratories to Sell the Assets of its CBI Services and Fairfax Identity Laboratories Divisions
7/21/2009 11:48:15 AM
More...
|
LabConnect, LLC and Bostwick Scientific Launch Centralized Anatomic Pathology Testing Service
4/3/2008 9:21:53 AM
More...
|
Gastrocor(TM) Announces Appointment of Barbara A. Russo, M.D., as Associate Medical Director, Uniondale, New York
3/24/2008 10:18:52 AM
More...
|
|